Ashleigh Stewart

673 citations
15 papers · 425 indexed · h-index 6
Topics
Immunotherapy and Immune Responses (9 papers)Cancer Immunotherapy and Biomarkers (8 papers)CAR-T cell therapy research (4 papers)

In The Last Decade

Ashleigh Stewart

15 papers receiving 425 citations

Peers

Ashleigh Stewart
Comparison fields: 5 of 52
  • Oncology 278
  • Molecular Biology 209
  • Immunology 206
  • Cancer Research 44
  • Pulmonary and Respiratory Medicine 34
Replace Meri Rogava with:
Meri Rogava Germany
Sheera R. Rosenbaum United States
Marieke I.G. Raaijmakers Switzerland
Nicole Fer United States
Fernanda Costa Svedman Sweden
Jesper Zeuthen Denmark
Janice M. Mehnert United States
Pauline L. de Goeje Netherlands
Fred M. Kaplan United States
Helen L. Young United Kingdom
Ashleigh Stewart relative to Meri Rogava Germany Meri Rogava's profile →
Citations per field
00.5×1.5×2.3×
Meri Rogava · 1×
Citations per year

Countries citing papers authored by Ashleigh Stewart

Since Specialization
Citations

This map shows the geographic impact of Ashleigh Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashleigh Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashleigh Stewart more than expected).

Fields of papers citing papers by Ashleigh Stewart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashleigh Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashleigh Stewart. The network helps show where Ashleigh Stewart may publish in the future.

Co-authorship network of co-authors of Ashleigh Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of Ashleigh Stewart. A scholar is included among the top collaborators of Ashleigh Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashleigh Stewart. Ashleigh Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 4
2 1
3 1
4 5
5 67
6 5
7 1
8 12
9 2
10 3
11 193
12 31
13 1
14 71
15 28

About Ashleigh Stewart

Ashleigh Stewart is a scholar working on Ophthalmology, Immunology and Oncology, having authored 15 papers that have together received 425 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Oncology (278 citations), Immunology (206 citations) and Molecular Biology (209 citations). Ashleigh Stewart has collaborated with scholars based in Australia, Netherlands and Germany. Frequent co-authors include Helen Rizos, Bernadette Pedersen, Richard Kefford, Su Yin Lim, Elena Shklovskaya, Matteo S. Carlino, Jenny Lee, Georgina V. Long, Richard A. Scolyer and Robyn P.M. Saw. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026